Skip to main content
. 2019 Feb 28;34(1):60–70. doi: 10.4266/acc.2018.00311

Table 3.

Predictor for reintubation in HFNC group

Characteristics Non-reintubation (n=69) Reintubation (n=15) P-value
Male sex 49 (71.0) 11 (73.3) 1.000a
Age (yr) 74.0 (65.50–80.50) 72.00 (67.00–74.00) 0.245
Height (cm) 162.0 (158.0–170.0) 164.50 (160.00–165.00) 0.711
Body weight (kg) 58.0 (50.0–70.0) 55.30 (50.00–60.00) 0.656
Body mass index (kg/m2) 22.7 (18.7–24.9) 22.03 (19.59–23.44) 0.717
Underlying disease
 Diabetes mellitus 15 (21.7) 4 (26.7) 0.736a
 Hypertension 25 (36.2) 6 (40.0) 0.784
 Malignant disease 6 (8.7) 4 (26.7) 0.073a
 Chronic respiratory disease 40 (58.0) 7 (46.7) 0.424
 Chronic heart disease 18 (26.1) 4 (26.7) 1.000a
 Chronic liver disease 1 (1.4) 0 1.000a
 Chronic renal disease 7 (10.1) 4 (26.7) 0.102a
 Neurologic disease 20 (29.0) 7 (46.7) 0.226a
Cause of mechanical ventilation
 Pneumonia 36 (52.2) 9 (60.0) 0.776
 Airway disease 9 (13.0) 4 (26.7) 0.235a
 Hemoptysis 3 (4.3) 0 1.000a
 Drug intoxication 13 (18.8) 1 (6.7) 0.447a
 Post operation 2 (2.9) 0 1.000a
 Heat failure 3 (4.3) 0 1.000a
 Others 3 (4.3) 1 (6.7) 0.552a
Type of respiratory failure at intubationb
 Tachypneic respiratory failure 5 (7.2) 1 (6.7) 1.000a
 Hypercapnic respiratory failure 31 (44.9) 7 (46.7) 0.902
 Hypoxic respiratory failure 22 (31.9) 1 (6.7) 0.058a
 Othersc 15 (21.7) 7 (46.7) 0.058a
Severity index
 APACHE II score at ICU admission 22.0 (17.50–25.00) 22.00 (19.00–25.00) 0.516
 APACHE II score at extubation 17.0 (15.0–19.0) 16.00 (13.00–22.00) 0.541
Vital sign and arterial blood gas before intubation
 Heart rate 100.00 (84.00–124.50) 101.00 (88.00–118.00) 0.820
 Respiratory rate 22.00 (18.00–26.00) 22.00 (18.00–28.00) 0.977
 PaCO2 (mmHg) 44.90 (30.50–60.95) 38.60 (32.00–86.00) 0.356
 PaO2/FiO2 (mmHg) 131.97 (86.90–256.19) 120.86 (80.12–291.90) 0.907
 (A–a) DO2 186.97 (48.71–411.96) 179.53 (50.43- 465.58) 0.532
Vital sign and arterial blood gas before extubation
 Heart rate on ventilation 82.00 (73.50–101.00) 87.00 (76.00–109.00) 0.272
 Respiratory rate on ventilation 18.00 (16.00–21.00) 18.00 (15.00–20.00) 0.366
 PaCO2 on ventilation (mmHg) 34.60 (30.50–40.30) 35.40 (27.70–46.80) 0.717
 PaO2/FiO2 on ventilation (mmHg) 286.75 (215.62–361.00) 321.00 (165.75–400.00) 0.939
 (A–a) DO2 at spontaneous breathing trial 143.62 (110.02–166.10) 123.42 (92.25–178.92) 0.640
High risk patient
 Age older than 65 years 53 (76.8) 12 (80.0) 1.000a
 Body mass index higher than 30 kg/m2 6 (8.7) 1 (6.7) 1.000a
 Ventilator duration more than 7 days 22 (31.9) 8 (53.3) 0.116
 Charlson comorbidity index of 2 or more 26 (37.7) 7 (46.7) 0.518a
 APACHE II score of more than 12 66 (95.7) 14 (93.3) 0.552a
 Heart failure as a cause of intubation 3 (4.3) 0 1.000a
 Moderate to severe COPD 15 (21.7) 1 (6.7) 0.282a
 Failure with first SBT trial 40 (58.0) 12 (80.0) 0.111
Duration of mechanical ventilation before extubation (hr) 117.15 (70.71–210.29) 181.46 (82.83–273.66) 0.197
Hospital day before extubation trial (day) 6.00 (4.00–10.00) 9.00 (8.00–14.00) 0.036

Values are presented as number (%) or median (interquartile range).

HFNC: high-flow nasal cannula; APACHE: Acute Physiologic and Chronic Health Evaluation; ICU: intensive care unit; PaCO2: arterial partial pressure of carbon dioxide; PaO2/FiO2: ratio of arterial oxygen partial pressure to fractional inspired oxygen; (A–a) DO2: alveolar–arterial oxygen difference; COPD: chronic obstructive pulmonary disease; SBT: spontaneous breathing trial.

a

Fisher exact test;

b

Type of respiratory failure can be classified according to each group, if it satisfies both criteria;

c

Respiratory failure that was not satisfy each criterion.